Peb zoo siab tshaj tawm tias JYMed yuav nthuav tawm ntawm Interphex Week Tokyo thaum Lub Xya Hli 9 txog 11, 2025, ntawm Tokyo Big Sight (Ariake). Qhov kev tshwm sim loj no coj los ua ke ntau dua 90 tus neeg tuaj koom thiab kwv yees li 34,000 tus kws tshaj lij los ntawm thoob plaws kev lag luam tshuaj thiab tshuaj pleev ib ce. Raws li ib qho ntawm Asia cov platforms saum toj kawg nkaus rau kev lag luam kev lag luam thiab kev lag luam thoob ntiaj teb, Interphex Tokyo yog lub sijhawm tseem ceeb rau kev sib koom tes thoob ntiaj teb.

Hais txog JYMed

JYMed yog lub tuam txhab kev tshawb fawb-tsav tshuaj tshwj xeeb hauv kev tsim kho, tsim khoom, thiab kev lag luam ntawm cov khoom siv peptide. Peb muab cov kev pabcuam CDMO kawg rau cov kws kho mob, tshuaj pleev ib ce, thiab kws kho tsiaj thoob ntiaj teb.

Peb cov khoom lag luam suav nrog ntau yam peptide APIs, suav nrog Semaglutide thiab Tirzepatide, ob qho tib si tau ua tiav US FDA DMF cov ntaub ntawv.

Peb lub tuam txhab tsim khoom, Hubei JXBio, ua haujlwm txiav peptide API cov kab ntau lawm uas ua tau raws li cov qauv cGMP los ntawm US FDA thiab Tuam Tshoj NMPA. Lub vev xaib muaj 10 cov kab loj- thiab kev tsav dav hlau thiab tau txais kev txhawb nqa los ntawm QMS muaj zog thiab cov txheej txheem EHS.

JXBio tau dhau GMP kev tshuaj xyuas los ntawm US FDA thiab Tuam Tshoj NMPA thiab tau lees paub los ntawm cov tuam txhab kws tshuaj rau nws txoj kev cog lus rau kev nyab xeeb, zoo, thiab lub luag haujlwm ib puag ncig.

MAIN khoom

Cia peb sib txuas

Xav paub ntau ntxiv txog peb lub peev xwm lossis teem caij lub rooj sib tham thaum lub sijhawm ua yeeb yam:

•Ntiaj teb API & Tshuaj pleev ib ce nug:+86-150-1352-9272

•API Registration & CDMO Services (US & EU):+86-158-1868-2250

•Email: jymed@jymedtech.com

•Chaw nyob:Floors 8 & 9, Building 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi District, Pingshan District, Shenzhen, Suav.